Methods of treating FGF21-associated disorders

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11236159
APP PUB NO 20200087392A1
SERIAL NO

15749775

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGLICHTSTRASSE 35 BASEL 4056

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boettcher, Brian Winchester, US 3 1
Caplan, Shari Lynn Lunenburg, US 11 62
Cebe, Regis Saint-Louis, FR 14 12
Li, Guochun San Diego, US 4 0
Taraszka, John A Arlington, US 10 280
Xu, Fangmin Belmont, US 33 680
Yowe, David Langdon Belmont, US 7 96

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 1, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 1, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 1, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00